For the readers interested in the stock health of Spectrum Pharmaceuticals Inc. (SPPI). It is currently valued at $3.37. When the transactions were called off in the previous session, Stock hit the highs of $3.55, after setting-off with the price of $3.39. Company’s stock value dipped to $3.381 during the trading on the day. When the trading was stopped its value was $3.49.
Recently in News on June 4, 2021, Spectrum Pharmaceuticals Presents Poziotinib Data in Patients with Brain Metastases from the ZENITH20 Clinical Trial at 2021 ASCO Annual Meeting. Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented an e-poster on poziotinib CNS activity in patients with NSCLC with EGFR or HER2 exon 20 mutations. These data from Cohorts 1, 2 and 3 of the ongoing ZENITH20 clinical trial assessed the results from 36 patients with brain metastases at baseline with three patients (8%) achieving intracranial complete responses. The presentation titled “CNS activity of poziotinib in NSCLC with exon 20 insertion mutations” is available on the website for the 2021 ASCO Annual Meeting being held June 4-8, 2021. You can read further details here
Spectrum Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.54 on 06/14/21, with the lowest value was $2.82 for the same time period, recorded on 04/13/21.
Spectrum Pharmaceuticals Inc. (SPPI) full year performance was 1.16%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Spectrum Pharmaceuticals Inc. shares are logging -35.69% during the 52-week period from high price, and 19.50% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.82 and $5.24.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 636295 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Spectrum Pharmaceuticals Inc. (SPPI) recorded performance in the market was 2.35%, having the revenues showcasing 16.14% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 573.65M, as it employees total of 176 workers.
Spectrum Pharmaceuticals Inc. (SPPI) in the eye of market guru’s
During the last month, 0 analysts gave the Spectrum Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.45, with a change in the price was noted -0.23. In a similar fashion, Spectrum Pharmaceuticals Inc. posted a movement of -6.37% for the period of last 100 days, recording 2,735,897 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SPPI is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Spectrum Pharmaceuticals Inc. (SPPI): Stocks Technical analysis and Trends
Raw Stochastic average of Spectrum Pharmaceuticals Inc. in the period of last 50 days is set at 25.16%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 12.50%. In the last 20 days, the company’s Stochastic %K was 17.46% and its Stochastic %D was recorded 13.22%.
If we look into the earlier routines of Spectrum Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 2.35%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -14.67%, alongside a boost of 1.16% for the period of the last 12 months. The shares increased approximately by 2.05% in the 7-day charts and went up by -16.51% in the period of the last 30 days. Common stock shares were driven by 16.14% during last recorded quarter.